Malignancies following bilateral salpingo-oophorectomy (BSO)

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
W H GotliebE Friedman

Abstract

Prophylactic bilateral salpingo-oophorectomy (BSO) is an effective risk reducing measure in ovarian cancer susceptible women. Yet, a small subset of women develop primary peritoneal carcinomatosis (PPC) after BSO. The rates of PPC following non-risk reducing BSO have sparingly been reported. Women who underwent BSO for non-cancer reasons from 1/1/1984 to 12/31/2000 were crossed with the list of cancer diagnoses reported to the Israel National Cancer Registry until 12/31/2001. Overall, 4128 women at a mean age of 58+/-12 years were analyzed. After a mean of 7.2+/-4 years following BSO, 147 women (3.6%) were diagnosed with cancer: breast cancer in 50 women 62+/-50 months after BSO, and one patient developed PPC, whereas the expected was 0.15 cases. The Standardized Incidence Ratio (SIR) of developing breast cancer was statistically significant lower than expected (SIR 0.71, 95% C.I. 0.44-0.78). The rate of post-oophorectomy PPC in average risk population is low, and BSO appears to lower the rate of breast cancer in average risk women.

References

Sep 1, 1996·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A KontoravdisP A Zourlas
Jan 17, 1997·International Journal of Cancer. Journal International Du Cancer·C SchairerL A Brinton
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G GattaA Verdecchia
Oct 3, 2000·Gynecologic and Obstetric Investigation·G CormioL Selvaggi
May 25, 2002·The New England Journal of Medicine·Noah D KauffKenneth Offit
May 25, 2002·The New England Journal of Medicine·Timothy R RebbeckUNKNOWN Prevention and Observation of Surgical End Points Study Group
Dec 4, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J EngelD Hölzel
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Douglas A LevineJeff Boyd
Jan 14, 2004·The Journal of Obstetrics and Gynaecology Research·Kittipat CharoenkwanChalong Cheewakriangkrai
Feb 27, 2004·The Breast Journal·Olufunmilayo I Olopade, Grazia Artioli
Sep 3, 2004·Nature Reviews. Cancer·Steven A Narod, William D Foulkes
Nov 2, 2004·Familial Cancer·Murray Joseph Casey, Chhanda Bewtra

❮ Previous
Next ❯

Citations

May 12, 2010·Breast Cancer Research and Treatment·Larissa A KordePhuong L Mai
Sep 19, 2009·Expert Opinion on Pharmacotherapy·Gerald M Higa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.